Medicentres Limited - Accounts to registrar (filleted) - small 18.2

Medicentres Limited - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v19.2.0.596 01377934 Board of Directors 1.8.18 31.7.19 31.7.19 false true false false true false Fair value model iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure013779342018-07-31013779342019-07-31013779342018-08-012019-07-31013779342017-07-31013779342017-08-012018-07-31013779342018-07-3101377934ns15:EnglandWales2018-08-012019-07-3101377934ns14:PoundSterling2018-08-012019-07-3101377934ns10:Director12018-08-012019-07-3101377934ns10:PrivateLimitedCompanyLtd2018-08-012019-07-3101377934ns10:SmallEntities2018-08-012019-07-3101377934ns10:AuditExempt-NoAccountantsReport2018-08-012019-07-3101377934ns10:SmallCompaniesRegimeForDirectorsReport2018-08-012019-07-3101377934ns10:SmallCompaniesRegimeForAccounts2018-08-012019-07-3101377934ns10:FullAccounts2018-08-012019-07-3101377934ns10:Director22018-08-012019-07-3101377934ns10:CompanySecretary12018-08-012019-07-3101377934ns10:RegisteredOffice2018-08-012019-07-3101377934ns5:CurrentFinancialInstruments2019-07-3101377934ns5:CurrentFinancialInstruments2018-07-3101377934ns5:ShareCapital2019-07-3101377934ns5:ShareCapital2018-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2019-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2018-07-3101377934ns5:RetainedEarningsAccumulatedLosses2019-07-3101377934ns5:RetainedEarningsAccumulatedLosses2018-07-3101377934ns5:PlantMachinery2018-08-012019-07-3101377934ns5:ComputerEquipment2018-08-012019-07-3101377934ns5:PlantMachinery2018-07-3101377934ns5:ComputerEquipment2018-07-3101377934ns5:PlantMachinery2019-07-3101377934ns5:ComputerEquipment2019-07-3101377934ns5:PlantMachinery2018-07-3101377934ns5:ComputerEquipment2018-07-3101377934ns5:RetainedEarningsAccumulatedLosses2018-07-3101377934ns5:FurtherSpecificReserve2ComponentTotalEquity2018-07-3101377934ns5:RetainedEarningsAccumulatedLosses2018-08-012019-07-31


REGISTERED NUMBER: 01377934 (England and Wales)


















UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 JULY 2019

FOR

MEDICENTRES LIMITED

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)






CONTENTS OF THE FINANCIAL STATEMENTS
for the Year Ended 31 July 2019




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 3


MEDICENTRES LIMITED

COMPANY INFORMATION
for the Year Ended 31 July 2019







DIRECTORS: Dr B W O'Brien
Mrs C O'Brien





SECRETARY: Mrs C O'Brien





REGISTERED OFFICE: Beech Croft
51 Ruff Lane
Ormskirk
Lancashire
L39 4UL





REGISTERED NUMBER: 01377934 (England and Wales)





ACCOUNTANTS: Fairhurst
Chartered Accountants
Douglas Bank House
Wigan Lane
Wigan
Lancashire
WN1 2TB

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

STATEMENT OF FINANCIAL POSITION
31 July 2019

2019 2018
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 569 759
Investment property 5 352,500 280,000
353,069 280,759

CURRENT ASSETS
Cash at bank 12,583 85,727

CREDITORS
Amounts falling due within one year 6 7,014 6,868
NET CURRENT ASSETS 5,569 78,859
TOTAL ASSETS LESS CURRENT
LIABILITIES

358,638

359,618

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Other reserves 7 57,211 57,211
Retained earnings 7 300,427 301,407
SHAREHOLDERS' FUNDS 358,638 359,618

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 4 November 2019 and were signed on its behalf
by:





Dr B W O'Brien - Director


MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS
for the Year Ended 31 July 2019

1. STATUTORY INFORMATION

Medicentres Limited is a private company, limited by shares , registered in England and Wales. The company's
registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery - 25% on reducing balance
Computer equipment - 25% on reducing balance

Tangible fixed assets are recorded at cost or valuation, less depreciation and impairment.

Impairment of assets
At each reporting date assets are reviewed to determine whether there is any indication that those assets have
suffered an impairment loss. If there is an indication of possible impairment, the recoverable amount of any
affected asset is estimated and compared with its carrying amount. If the estimated recoverable amount is lower,
the carrying amount is reduced to its estimated recoverable amount, and an impairment loss is recognised
immediately in the profit and loss.

Where an impairment loss subsequently reverses, the carrying amount of each asset is increased to the revised
estimate of its recoverable amount, to the extent that the increased carrying amount does not exceed the carrying
amount that would have been determined (net of depreciation) had no impairment loss been recognised for the
asset in prior years. A reversal of an impairment loss is recognised as income immediately.

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in
fair value is recognised in profit or loss.

Deferred tax is provided on these gains at the rate expected to apply when the property is sold.

Financial instruments
Short term trade creditors are measured at transaction price. Financial liabilities that have no stated interest rate
and are payable within one year shall be measured at the undiscounted amount due.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the statement of financial position date.


MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2019

2. ACCOUNTING POLICIES - continued
Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the
statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was NIL (2018 - 2 ).

4. TANGIBLE FIXED ASSETS
Plant and Computer
machinery equipment Totals
£    £    £   
COST
At 1 August 2018
and 31 July 2019 9,687 3,332 13,019
DEPRECIATION
At 1 August 2018 9,423 2,837 12,260
Charge for year 66 124 190
At 31 July 2019 9,489 2,961 12,450
NET BOOK VALUE
At 31 July 2019 198 371 569
At 31 July 2018 264 495 759

5. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 August 2018 280,000
Additions 72,500
At 31 July 2019 352,500
NET BOOK VALUE
At 31 July 2019 352,500
At 31 July 2018 280,000

The investment properties were valued on 31 July by the directors who consider it not materially different to the
brought forward value as stated in these financial statements.

MEDICENTRES LIMITED (REGISTERED NUMBER: 01377934)

NOTES TO THE FINANCIAL STATEMENTS - continued
for the Year Ended 31 July 2019

5. INVESTMENT PROPERTY - continued

Fair value at 31 July 2019 is represented by:

£   
Valuation in 2004 17,898
Valuation in 2006 34,313
Valuation in 2013 5,000
Valuation in 2018 72,500
Cost 222,789
352,500

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2019 2018
£    £   
Other creditors 7,014 6,868

7. RESERVES
Retained Other
earnings reserves Totals
£    £    £   

At 1 August 2018 301,407 57,211 358,618
Profit for the year 2,866 2,866
Dividends (3,846 ) (3,846 )
At 31 July 2019 300,427 57,211 357,638